Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3Yuanchen Liu, Hin Chu, Jie Zhou et al.|Nature Communications|2024Cited by 46
Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tractBingjie Hu, Hin Chu, Shuofeng Yuan et al.|EBioMedicine|2023Cited by 22
Pathogenicity, virological features, and immune evasion of SARS-CoV-2 JN.1-derived variants including JN.1.7, KP.2, KP.3, and KP.3.1.1Jialu Shi, Hin Chu, Jie Zhou et al.|Nature Communications|2025Cited by 6
Type‐II IFN inhibits SARS‐CoV‐2 replication in human lung epithelial cells and ex vivo human lung tissues through indoleamine 2,3‐dioxygenase‐mediated pathwaysDong Yang, Hin Chu, Ko‐Yung Sit et al.|Journal of Medical Virology|2024Cited by 4